Condition: Type 1 Diabetes · Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Bone damage is frequently observed in type 1 diabetes, and hyperglycemia is associated with an increased risk of fracture. This pilot study in 25 people living with type 1 diabetes aims to determine whether the introduction of an automated insulin delivery (AID) system improves bone markers through rapide optimization of glycemic control. Measurements will be taken before the start of AID, 2 months and 4 months afterwards.
This description comes directly from the study's public registry record.
Elisabeth Nguyen · 514-987-5617 · elisabeth.nguyen@ircm.qc.ca
Valérie Boudreau · 514-987-5643 · valerie.boudreau@ircm.qc.ca
Always discuss trial participation with your own doctor first.
| CHUM | Montreal, Quebec, Canada | Recruiting |
| Centre Hospitalier de l'Université de Montréal | Montreal, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06158503